KLRC1 and Miyoshi myopathy: Interestingly, HLA-E overexpression in tumors was connected to both poor and good prognosis (225, 226) Although there are data suggesting that the expression of NKG2A is not detrimental for the anti-MM activity of in vitro activated NK cells, NKG2A is still a valid target for consideration in immunotherapy.